- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03939299
OCT Explores Vascular Response and Healing Profile After Stenting in CTO
3. maj 2019 opdateret af: Shanghai Zhongshan Hospital
Optical Coherence Tomography Imaging Explores Long-term vasculAR Response and Healing profIle After successFul coronarY Stenting in Chronic Total Occlusion
True-false-true occurred during wire penetration in coronary CTO procedure.
Subintimal stenting influences vascular response.
Intravenous ultrasound confirmed wire position in the procedure.
Then stenting procedure was performed.
Optical coherence tomography was used for exploring long-term vascular response and healing profile after successful coronary stenting in CTO lesions.
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Chronic total occlusions (CTOs) are defined as coronary lesions with thrombolysis in myocardial infarction (TIMI) grade flow of 0 and present for more than 3 months.
CTO is commonly recognized as the toughest lesion subset to be treated by percutaneous coronary interventions.
With the remarkable progress in the technologies and techniques achieved in the PCI for CTO over the last decade, the rate of procedural success increased to 80-90%.
Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts.
At present, four strategies were used for CTO lesions, including: ante-grade wire escalation, ante-grade dissection reentry (ADR), retro-grade wire escalation, and retrograde dissection reentry (RDR).
True-false-true occurred during wire penetration.
Subintimal stenting influences vascular response.
Intravenous ultrasound (IVUS) confirmed wire position in the procedure.
Then stenting procedure was performed according to standard routine.
Optical coherence tomography (OCT) was used for exploring long-term vascular response and healing profile after successful coronary stenting in CTO lesions.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
60
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Hongbo Yang, M.D.
- Telefonnummer: 008613585890793
- E-mail: yang.hongbo@zs-hospital.sh.cn
Undersøgelse Kontakt Backup
- Navn: Zhangwei Chen, Ph.D.
- Telefonnummer: 008613918612111
- E-mail: chen.zhangwei@zs-hospital.sh.cn
Studiesteder
-
-
Shanghai
-
Shanghai, Shanghai, Kina, 200032
- Rekruttering
- Zhongshan Hospital, Fudan University
-
Kontakt:
- Hongbo Yang, M.D.
- Telefonnummer: 008613585890793
- E-mail: yang.hongbo@zs-hospital.sh.cn
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 85 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- 18~85 years old;
- Agree percutaneous coronary intervention without related contraindications;
- Chronic total occlusion confirmed by clinical and angiographic data, predicted high successful rate of stent implantation;
- Subjects (or legal guardians) understanding the testing requirements and procedures, and providing written informed consent.
Exclusion Criteria:
- Subjects associated with drugs allergy (such as contrast, sirolimus, or structure-related compounds fluorinated polymers, thienopyridine or aspirin);
- Subjects with active peptic ulcer, active gastrointestinal (GI) bleeding or other bleeding diathesis or coagulopathy;
- Subjects being suffered from other serious illness (such as cancer, congestive heart failure), which may cause drop in life expectancy to less than 12 months;
- Pregnant or breastfeeding women;
- Refused this trial;
- Subjects with severe liver or renal dysfunction (ALT >5×ULN,eGFR< 30ml/min/1.73mm2 or Scr>200 mmol/L);
- Active bleeding;
- Bleeding diathesis or coagulopathy, malignant tumors;
- Contraindication of anticoagulant drugs;
- Subjects with other situation not suitable for the study.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: OCT group
Patients, whose coronary chronic total occlusion lesion was successfully implanted stent, received optical coherence tomography imaging immediately and at 9-12 months after index procedure.
|
Patients with coronary chronic total occlusion received successful stenting.
Optimal coherence tomography imaged immediately and at 9-12 months after the index procedure to explore long-term vascular response and healing profile.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
long-term minimal stent area
Tidsramme: 9-12 month after index procedure
|
measured through OCT imaging result
|
9-12 month after index procedure
|
|
long-term stent thrombosis
Tidsramme: 9-12 month after index procedure
|
measured through OCT imaging result
|
9-12 month after index procedure
|
|
long-term stent neointima
Tidsramme: 9-12 month after index procedure
|
measured through OCT imaging result
|
9-12 month after index procedure
|
|
long-term stent malapposition
Tidsramme: 9-12 month after index procedure
|
measured through OCT imaging result
|
9-12 month after index procedure
|
|
immediately minimal stent area
Tidsramme: in the procedure
|
measured through OCT imaging result
|
in the procedure
|
|
immediately stent malapposition
Tidsramme: in the procedure
|
measured through OCT imaging result
|
in the procedure
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Major Adverse Cardiovascular Events
Tidsramme: 9-12 month after index procedure
|
clinical follow-up record
|
9-12 month after index procedure
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Juying Qian, Professor, Fudan University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
15. april 2019
Primær færdiggørelse (Forventet)
31. december 2023
Studieafslutning (Forventet)
31. december 2023
Datoer for studieregistrering
Først indsendt
29. april 2019
Først indsendt, der opfyldte QC-kriterier
3. maj 2019
Først opslået (Faktiske)
6. maj 2019
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
6. maj 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
3. maj 2019
Sidst verificeret
1. maj 2019
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- CLARIFY-CTO
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kronisk total okklusion af koronararterie
-
IRCCS Policlinico S. DonatoRekrutteringAnomalous aorta origin of the coronary artery (AAOCA)Italien
-
IRCCS Policlinico S. DonatoUniversity of Pavia; University of Naples; The Mediterranean Institute for...RekrutteringMyokardieiskæmi | Pludselig hjertedød | Anomal koronararterieoprindelse | Anomal koronararterie, der opstår fra den modsatte sinus | Anomal koronararterie med aorta-oprindelse og forløb mellem de store arterier | Anomalous aorta origin of the coronary artery (AAOCA) | Myokardieiskæmi, Angina Pectoris og andre forholdItalien
Kliniske forsøg med OCT
-
Assiut UniversityIkke rekrutterer endnuProliferativ diabetisk retinopati
-
Vienna Institute for Research in Ocular SurgeryAfsluttet
-
Centre Hospitalier Intercommunal CreteilTrukket tilbage
-
Memorial Sloan Kettering Cancer CenterIntalight, IncRekrutteringØjentumorForenede Stater
-
Centre Hospitalier Intercommunal CreteilAfsluttet
-
University Hospital Inselspital, BerneRekrutteringGrøn stær | Makuladegeneration | Uveitis | Diabetisk retinopati | Diabetisk makulært ødem | Makulaødem | Retinal veneokklusion | Synsnervesygdomme | Nethindeløsning | Makula sygdom | Nethindesygdom | Retinal neovaskularisering | Nethindearterieokklusion | Hypertensiv retinopati | Nethindeødem | NethindedystrofiSchweiz
-
Topcon CorporationAfsluttetFluorescein angiografi billeddannelseForenede Stater
-
Assiut UniversityIkke rekrutterer endnu
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRekruttering